Matches in Nanopublications for { ?s ?p "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP918749.RAbYmfaTiuTmNtuqeOXYYslFpmTGmkUL5BFa_KZbQl0ro130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP918749.RAbYmfaTiuTmNtuqeOXYYslFpmTGmkUL5BFa_KZbQl0ro130_provenance.
- NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP853813.RAkCY2rTdMal9UnylkzLcypgYQZmsErl4yOq-hDXRN8Ig130_provenance.
- NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749004.RACmn0WQg9dutEZb7qAESv8zorYTswVs0F5JgEDjx2fCQ130_provenance.
- NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP748919.RA8GDn2UZq-3RskT0AA6VeEmqw1o5CxIddmQk__plYO00130_provenance.
- NP1048663.RA0f6amgjtKhKZ-HQqHq52voUHErfYJEg8oQgz5Qzt0iY130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048663.RA0f6amgjtKhKZ-HQqHq52voUHErfYJEg8oQgz5Qzt0iY130_provenance.
- NP1048665.RA-ibql4As5sSielhUQfw8oMcrcISEaTpJS5QZzoPGSNA130_assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1048665.RA-ibql4As5sSielhUQfw8oMcrcISEaTpJS5QZzoPGSNA130_provenance.
- assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Hydroxycamptothecin (HCPT) is a DNA topoisomerase I inhibitor, which has been utilized in chemotherapy for bladder cancer for nearly 40 years.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.